Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus

The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus

(2016) Laura K. McMullan et al.   ANTIVIRAL RESEARCH

Characterization of Yellow Fever Virus Infection of Human and Non-human Primate Antigen Presenting Cells and Their Interaction with CD4+ T Cells

(2016) Yu Cong et al.   PLoS Neglected Tropical Diseases

A Rapid Screening Assay Identifies Monotherapy with Interferon-ß and Combination Therapies with Nucleoside Analogs as Effective Inhibitors of Ebola Virus

(2016) Stephen D. S. McCarthy et al.   PLoS Neglected Tropical Diseases

Drug repositioning and repurposing: terminology and definitions in literature

(2015) Joris Langedijk et al.   DRUG DISCOVERY TODAY

Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment

(2015) Yasuteru Sakurai et al.   SCIENCE

Against the clock towards new Ebola virus therapies

(2015) Carles Martínez-Romero et al.   VIRUS RESEARCH

Viruses and disease: emerging concepts for prevention, diagnosis and treatment

(2014) CS Herrington et al.   JOURNAL OF PATHOLOGY

FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection

(2013) L. M. Johansen et al.   Science Translational Medicine

Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression

(2012) Kerstin Gnirß et al.   VIROLOGY

Pharmacokinetics of Lamivudine and Lamivudine-Triphosphate after Administration of 300 Milligrams and 150 Milligrams Once Daily to Healthy Volunteers: Results of the ENCORE 2 Study

(2011) Laura J. Else et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Emergence of Divergent Zaire Ebola Virus Strains in Democratic Republic of the Congo in 2007 and 2008

(2011) G. Grard et al.   JOURNAL OF INFECTIOUS DISEASES

Systematic exploration of synergistic drug pairs

(2011) M. Cokol et al.   Molecular Systems Biology